To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer | MicrobiomeTrials← Back to trialsNCT07647744
To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2029-06
Enrollment target: 18 participants Locations- RenJi Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Other microbiome trials you might be interested in
Metastatic Clear Cell Renal Cell Carcinoma
The purpose of this study is to evaluate the safety and feasibility of a treatment holiday strategy directed by CD70-tar…
Nanjing, ChinaEst. completion Aug 10, 2028
Renal Cell Carcinoma
There are limited data regarding the biology and treatment of TFE Renal Cell Carcinoma (TFE RCC). This project provides …
Cincinnati, United StatesCompleted Mar 30, 2026
Recruiting
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8TFE3-Rearranged Renal Cell CarcinomaUnresectable Renal Cell Carcinoma
This phase II trial studies how well axitinib and nivolumab work in treating patients with TFE/translocation renal cell …
Birmingham, United StatesEst. completion Sep 30, 2024